USC receives $6 million grant for pioneering glioblastoma gene therapy

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it

No­vo Nordisk li­censed an ex­per­i­men­tal obe­si­ty pill from Er­a­Cal Ther­a­peu­tics in a deal worth €235 mil­lion, or rough­ly $255 mil­lion, as it hunts for the